Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity

Citation
F. Bauer et al., Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity, PROTEIN SCI, 10(12), 2001, pp. 2470-2479
Citations number
46
Categorie Soggetti
Biochemistry & Biophysics
Journal title
PROTEIN SCIENCE
ISSN journal
09618368 → ACNP
Volume
10
Issue
12
Year of publication
2001
Pages
2470 - 2479
Database
ISI
SICI code
0961-8368(200112)10:12<2470:SDOHAM>2.0.ZU;2-#
Abstract
Defensins are cationic and cysteine-rich peptides that play a crucial role in the host defense against microorganisms of many organisms by their capab ility to permeabilize bacterial membranes. The low sequence similarity amon g the members of the large mammalian beta -defensin family suggests that th eir antimicrobial activity is largely independent of their primary structur e. To investigate to what extent these defensins share a similar fold, the structures of the two human beta -defensins, hBD-1 and hBD-2, as well as th ose of two novel murine defensins, termed mBD-7 and mBD-8, were determined by nuclear magnetic resonance spectroscopy. All four defensins investigated share a striking similarity on the level of secondary and tertiary structu re including the lack of a distinct hydrophobic core, suggesting that the f old is mainly stabilized by the presence of three disulfide bonds. In addit ion to the overall shape of the molecules, the ratio of solvent-exposed pol ar and hydrophobic side chains is also very similar among the four defensin s investigated. It is significant that beta -defensins do not exhibit a com mon pattern of charged and hydrophobic residues on the protein surface and that the beta -defensin-specific fold appears to accommodate a wide range o f different amino acids at most sequence positions. In addition to the impl ications for the mode of biological defensin actions, these findings are of particular interest because beta -defensins have been suggested as lead co mpounds for the development of novel peptide antibiotics for the therapy of infectious diseases.